Sponsor Pipeline

Marea Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT07028749
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Enrollment reopened
2026-08-06 NCT07028749
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Enrollment increased: 216 -> 316 participants
2026-08-06 NCT07028749
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Trial arms changed: 3 -> 4
2026-08-06 NCT07028749
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
date change Primary completion pushed: 2026-07 -> 2027-11
2026-08-06 NCT07028749
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
date change Completion pushed: 2026-12 -> 2028-04
Active Trials by Phase
Phase 2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07199309 A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant… Hypertriglyceridemia Recruiting
NCT07028749 Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol Hypertriglyceridemia Recruiting
NCT07641179 A Study to Evaluate MAR002 for Acromegaly Acromegaly Not Yet Recruiting
Phase 1
NCT07195175 Study of MAR002 in Healthy Men Acromegaly Recruiting
Get alerts when Marea Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free